Avid Bioservices, Inc. - Common Stock (CDMO)
Frequently Asked Questions About Avid Bioservices, Inc. - Common Stock (CDMO)
Are there any risks associated with investing in Avid Bioservices?
Like all investments, there are risks associated with investing in Avid Bioservices, including market volatility, regulatory changes, and operational challenges. Potential investors should conduct thorough research and consider their risk tolerance.
Has Avid Bioservices made any acquisitions?
Avid Bioservices has engaged in strategic acquisitions in the past to enhance its service offerings and capabilities. Specific details about recent acquisitions can be found in the company's announcements and SEC filings.
How can I stay updated on Avid Bioservices?
To stay updated on Avid Bioservices, investors and interested parties can visit the company's official website, subscribe to newsletters, follow their press releases, and monitor their investor relations page for the latest information and financial reports.
How does Avid Bioservices contribute to drug development?
Avid Bioservices supports drug development by providing essential services at various stages of the biopharmaceutical lifecycle, including preclinical development and commercial manufacturing. Their expertise helps clients efficiently bring new therapies to the market.
Is Avid Bioservices publicly traded?
Yes, Avid Bioservices is publicly traded on the Nasdaq stock exchange under the ticker symbol CDMO. This allows investors to buy and sell shares in the company.
What are the growth prospects for Avid Bioservices?
The growth prospects for Avid Bioservices look promising due to the increasing demand for biologics and personalized medicine. As the biopharmaceutical industry continues to evolve, Avid is well-positioned to expand its offerings and client base.
What does Avid Bioservices, Inc. do?
Avid Bioservices, Inc. is a publicly traded company that specializes in contract development and manufacturing services for biopharmaceutical products. They focus primarily on the development and production of therapeutic proteins and monoclonal antibodies, leveraging their expertise in bioprocessing and a state-of-the-art facility.
What industries does Avid Bioservices serve?
Avid Bioservices serves the biopharmaceutical industry, specifically focusing on the development and manufacturing of therapeutic proteins and monoclonal antibodies. Their clients include biotechnology and pharmaceutical companies.
What is Avid Bioservices' approach to quality assurance?
Avid Bioservices places a strong emphasis on quality assurance, adhering to current Good Manufacturing Practices (cGMP) to ensure that all products are manufactured to the highest standards. This commitment to quality is essential for meeting regulatory requirements.
What is the competitive landscape for Avid Bioservices?
The competitive landscape for Avid Bioservices consists of other contract development and manufacturing organizations (CDMOs) in the biopharmaceutical sector. Avid differentiates itself through its commitment to quality and customer service.
What is the focus of Avid Bioservices' business model?
Avid Bioservices' business model is centered on providing high-quality contract services to biopharmaceutical companies looking to develop and manufacture biologics. This focus on contract services allows the company to build long-term relationships with clients.
What is the significance of Avid Bioservices' facility?
Avid Bioservices' facility is significant because it is designed to meet cGMP standards, enabling the company to manufacture products that comply with regulatory requirements for clinical and commercial use. The facility is equipped with cutting-edge technology.
What recent developments have occurred at Avid Bioservices?
Recent developments at Avid Bioservices may include new partnerships, expansions of their facilities, or advancements in their biomanufacturing capabilities. It is advisable to check their official press releases or financial reports for the latest updates.
What services does Avid Bioservices offer?
Avid Bioservices offers a range of services including cell line development, process development, upstream and downstream biomanufacturing, and quality control testing. These services support the full lifecycle of product development from early-stage research to commercial production.
What technologies does Avid Bioservices utilize?
Avid Bioservices utilizes advanced bioprocessing technologies, including high-density cell culture systems and chromatography techniques. These technologies enable the efficient production and purification of biologics.
When was Avid Bioservices founded?
Avid Bioservices was originally founded in 1984 under the name BioPacific Partners. It rebranded and adopted its current name in 2015, reflecting its commitment to providing bioservices to the pharmaceutical sector.
Where is Avid Bioservices headquartered?
Avid Bioservices is headquartered in Tustin, California. This location houses their laboratories and manufacturing capabilities, allowing them to provide high-quality services to their clients in the biopharmaceutical industry.
Who are Avid Bioservices' key customers?
Avid Bioservices serves a diverse range of clients, including small and mid-sized biotechnology firms as well as larger pharmaceutical companies. These clients rely on Avid's expertise for the development and manufacture of their therapeutic products.
Who leads Avid Bioservices?
Avid Bioservices is led by a team of experienced professionals in the biopharmaceutical industry, including a CEO and other executive officers who bring extensive expertise in drug development and manufacturing.
What is the current price of Avid Bioservices, Inc. - Common Stock?
The current price of Avid Bioservices, Inc. - Common Stock is 12.49
When was Avid Bioservices, Inc. - Common Stock last traded?
The last trade of Avid Bioservices, Inc. - Common Stock was at 4:00 pm EST on February 4th, 2025